Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

DBNDD2 (dysbindin domain containing 2)

Identity

Alias_namesC20orf35
chromosome 20 open reading frame 35
dysbindin (dystrobrevin binding protein 1) domain containing 2
Alias_symbol (synonym)HSMNP1
Other aliasCK1BP
HGNC (Hugo) DBNDD2
LocusID (NCBI) 55861
Atlas_Id 62305
Location 20q13.12  [Link to chromosome band 20q13]
Location_base_pair Starts at 45406015 and ends at 45410610 bp from pter ( according to hg38-Dec_2013)

Note

Non-annotated gene. Preliminary data : if you are an author
who wish to write a full paper/card on this gene, go to  How to contribute

DNA/RNA

 


External links

Nomenclature
HGNC (Hugo)DBNDD2   15881
Cards
Entrez_Gene (NCBI)DBNDD2  55861  dysbindin domain containing 2
AliasesC20orf35; CK1BP; HSMNP1
GeneCards (Weizmann)DBNDD2
Ensembl hg19 (Hinxton)ENSG00000244274 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000244274 [Gene_View]  chr20:45406015-45410610 [Contig_View]  DBNDD2 [Vega]
ICGC DataPortalENSG00000244274
TCGA cBioPortalDBNDD2
AceView (NCBI)DBNDD2
Genatlas (Paris)DBNDD2
WikiGenes55861
SOURCE (Princeton)DBNDD2
Genetics Home Reference (NIH)DBNDD2
Genomic and cartography
GoldenPath hg38 (UCSC)DBNDD2  -     chr20:45406015-45410610 +  20q13.12   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)DBNDD2  -     20q13.12   [Description]    (hg19-Feb_2009)
EnsemblDBNDD2 - 20q13.12 [CytoView hg19]  DBNDD2 - 20q13.12 [CytoView hg38]
Mapping of homologs : NCBIDBNDD2 [Mapview hg19]  DBNDD2 [Mapview hg38]
OMIM611453   
Gene and transcription
Genbank (Entrez)AF220191 AJ276469 AK000531 AL591565 AM393126
RefSeq transcript (Entrez)NM_001048221 NM_001048222 NM_001048223 NM_001048224 NM_001048225 NM_001048226 NM_001197139 NM_001197140 NM_018478
RefSeq genomic (Entrez)
Consensus coding sequences : CCDS (NCBI)DBNDD2
Cluster EST : UnigeneHs.730643 [ NCBI ]
CGAP (NCI)Hs.730643
Alternative Splicing GalleryENSG00000244274
Gene ExpressionDBNDD2 [ NCBI-GEO ]   DBNDD2 [ EBI - ARRAY_EXPRESS ]   DBNDD2 [ SEEK ]   DBNDD2 [ MEM ]
Gene Expression Viewer (FireBrowse)DBNDD2 [ Firebrowse - Broad ]
SOURCE (Princeton)Expression in : [Datasets]   [Normal Tissue Atlas]  [carcinoma Classsification]  [NCI60]
GenevisibleExpression in : [tissues]  [cell-lines]  [cancer]  [perturbations]  
BioGPS (Tissue expression)55861
GTEX Portal (Tissue expression)DBNDD2
Protein : pattern, domain, 3D structure
UniProt/SwissProtQ9BQY9   [function]  [subcellular_location]  [family_and_domains]  [pathology_and_biotech]  [ptm_processing]  [expression]  [interaction]
NextProtQ9BQY9  [Sequence]  [Exons]  [Medical]  [Publications]
With graphics : InterProQ9BQY9
Splice isoforms : SwissVarQ9BQY9
PhosPhoSitePlusQ9BQY9
Domains : Interpro (EBI)Dysbindin   
Domain families : Pfam (Sanger)Dysbindin (PF04440)   
Domain families : Pfam (NCBI)pfam04440   
Conserved Domain (NCBI)DBNDD2
DMDM Disease mutations55861
Blocks (Seattle)DBNDD2
SuperfamilyQ9BQY9
Human Protein AtlasENSG00000244274
Peptide AtlasQ9BQY9
HPRD12763
IPIIPI00983936   
Protein Interaction databases
DIP (DOE-UCLA)Q9BQY9
IntAct (EBI)Q9BQY9
FunCoupENSG00000244274
BioGRIDDBNDD2
STRING (EMBL)DBNDD2
ZODIACDBNDD2
Ontologies - Pathways
QuickGOQ9BQY9
Ontology : AmiGOprotein binding  cytoplasm  negative regulation of protein kinase activity  
Ontology : EGO-EBIprotein binding  cytoplasm  negative regulation of protein kinase activity  
NDEx NetworkDBNDD2
Atlas of Cancer Signalling NetworkDBNDD2
Wikipedia pathwaysDBNDD2
Orthology - Evolution
OrthoDB55861
GeneTree (enSembl)ENSG00000244274
Phylogenetic Trees/Animal Genes : TreeFamDBNDD2
HOVERGENQ9BQY9
HOGENOMQ9BQY9
Homologs : HomoloGeneDBNDD2
Homology/Alignments : Family Browser (UCSC)DBNDD2
Gene fusions - Rearrangements
Polymorphisms : SNP and Copy number variants
NCBI Variation ViewerDBNDD2 [hg38]
dbSNP Single Nucleotide Polymorphism (NCBI)DBNDD2
dbVarDBNDD2
ClinVarDBNDD2
1000_GenomesDBNDD2 
Exome Variant ServerDBNDD2
ExAC (Exome Aggregation Consortium)DBNDD2 (select the gene name)
Genetic variants : HAPMAP55861
Genomic Variants (DGV)DBNDD2 [DGVbeta]
DECIPHERDBNDD2 [patients]   [syndromes]   [variants]   [genes]  
CONAN: Copy Number AnalysisDBNDD2 
Mutations
ICGC Data PortalDBNDD2 
TCGA Data PortalDBNDD2 
Broad Tumor PortalDBNDD2
OASIS PortalDBNDD2 [ Somatic mutations - Copy number]
Somatic Mutations in Cancer : COSMICDBNDD2  [overview]  [genome browser]  [tissue]  [distribution]  
Mutations and Diseases : HGMDDBNDD2
LOVD (Leiden Open Variation Database)Whole genome datasets
LOVD (Leiden Open Variation Database)LOVD - Leiden Open Variation Database
LOVD (Leiden Open Variation Database)LOVD 3.0 shared installation
BioMutasearch DBNDD2
DgiDB (Drug Gene Interaction Database)DBNDD2
DoCM (Curated mutations)DBNDD2 (select the gene name)
CIViC (Clinical Interpretations of Variants in Cancer)DBNDD2 (select a term)
intoGenDBNDD2
Cancer3DDBNDD2(select the gene name)
Impact of mutations[PolyPhen2] [SIFT Human Coding SNP] [Buck Institute : MutDB] [Mutation Assessor] [Mutanalyser]
Diseases
OMIM611453   
Orphanet
MedgenDBNDD2
Genetic Testing Registry DBNDD2
NextProtQ9BQY9 [Medical]
TSGene55861
GENETestsDBNDD2
Target ValidationDBNDD2
Huge Navigator DBNDD2 [HugePedia]
snp3D : Map Gene to Disease55861
BioCentury BCIQDBNDD2
ClinGenDBNDD2
Clinical trials, drugs, therapy
Chemical/Protein Interactions : CTD55861
Chemical/Pharm GKB GenePA25749
Clinical trialDBNDD2
Miscellaneous
canSAR (ICR)DBNDD2 (select the gene name)
Probes
Litterature
PubMed17 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
CoreMineDBNDD2
EVEXDBNDD2
GoPubMedDBNDD2
iHOPDBNDD2
Genes in titleautomatic search in PubMed
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Jun 7 15:45:17 CEST 2017

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.